Trial · NCT07913711
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 22 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Other | Rome IV functional GI disorder profile | Baseline | Baseline functional gastrointestinal disorder characteristics as assessed by the Rome IV Diagnostic Questionnaire (R4DQ); administered at baseline only, used to characterize participants |
| Other | Change in at-home (direct-to-consumer) specimen assays | Baseline + Week 6 | Between-group differences in changes in specimen assay results from baseline to the end of study product usage (Week 6), among participants who consented to optional biospecimen collection. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07913711/registered?page=2